Novartis AG (NVS)

162.67 -1.25 (-0.76%) USD  |  NYSE  |  Feb 20, 16:00
163.99 +1.32 (+0.81%) Pre-Market: 20:00
More

Novartis Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for NVS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Roche Holding AG Upgrade
Amgen, Inc. Upgrade
AstraZeneca PLC Upgrade
Gilead Sciences, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade